Carmel Pharma AB is the world leader in closed drug transfer systems for handling of toxic drugs such as cytostatics and antibiotics. The company product system is named PhaSeal® and was introduced on the Swedish market in 1994. Since the start in Sweden, many millions of doses of hazardous drugs have been given with PhaSeal® protecting health care workers from dangerous exposure to the drugs.

In the last few years, the company has substantially expanded its operations in the US and the PhaSeal® system is now implemented in over 1 000 clinics on the North American market. Sales are conducted via the company's own sales organization in strategically important markets such as the USA, Germany, France, Canada, Japan and Sweden. On other markets, PhaSeal® is sold through distributors.

The company's head office and production unit is located in Mölndal, Sweden. The company has approximately 150 employees situated throughout the world.